Clinical Trials · NCT00667446
Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Enrollment
- 72
- Start date
- Dec 2008
- Locations
- 20 sites, United States, Puerto Rico
- Primary endpoint
- Percentage of Participants With Suppression of Peak-Stimulated Luteinizing Hormone